Reply to Mathon et al.

[1]  Mohammed Samannodi,et al.  Clinical Epidemiology, Risk Factors, and Outcomes of Encephalitis in Older Adults. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  E. Elliott,et al.  Causes and Clinical Features of Childhood Encephalitis: A Multicenter, Prospective Cohort Study. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. Boeve,et al.  Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis , 2018, Annals of neurology.

[4]  N. Crowcroft,et al.  Encephalitis, Ontario, Canada, 2002–2013 , 2016, Emerging infectious diseases.

[5]  C. Polage,et al.  State-of-the-Art Microbiologic Testing for Community-Acquired Meningitis and Encephalitis , 2016, Journal of Clinical Microbiology.

[6]  T. Solomon,et al.  Characteristic Cytokine and Chemokine Profiles in Encephalitis of Infectious, Immune-Mediated, and Unknown Aetiology , 2016, PloS one.

[7]  A. Rabinstein,et al.  The spectrum of acute encephalitis , 2015, Neurology.

[8]  A. Venkatesan,et al.  Predictors of outcome in acute encephalitis , 2013, Neurology.

[9]  A. Vincent,et al.  Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. , 2010, The Lancet. Infectious diseases.